Takeda Pharmaceutical Company Limited
Patents, Design & Utilities
Last updated:
List of all Takeda Pharmaceutical Company Limited patents 339 in total
| Status | Patent |
|---|---|
Grant | Utility: Heterocyclic compounds Filling date: 7 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Heterocyclic compound and use thereof Filling date: 7 Sep 2025 Issue date: 13 Sep 2022 |
Grant | Utility: Anti-CD38 antibodies Filling date: 7 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Formulation of an antibody and use thereof Filling date: 7 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: PURIFICATION OF FACTOR VIII SUBSPECIES Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: INFUSION SYSTEM Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 Filling date: 7 Sep 2025 Issue date: 30 Aug 2022 |
Application | Utility: ADENO-ASSOCIATED VIRUS PURIFICATION METHODS Filling date: 7 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: METHODS OF PRODUCING AN ANTI-a4B7 ANTIBODY Filling date: 7 Sep 2025 Issue date: 25 Aug 2022 |
Grant | Utility: Virus filtration of cell culture media Filling date: 7 Sep 2025 Issue date: 23 Aug 2022 |
Application | Utility: LYOPHILIZED RECOMBINANT VWF FORMULATIONS Filling date: 7 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF Filling date: 7 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: ANTIBODY DRUG CONJUGATES Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PROTEASOME INHIBITORS Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: TRANSFECTION METHOD Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: SCREENING METHOD AND TOXICITY EVALUATION METHOD Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: TRANSFECTION METHOD Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function Filling date: 7 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Constrained conditionally activated binding proteins Filling date: 7 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Methods for purification of arysulfatase A Filling date: 7 Sep 2025 Issue date: 9 Aug 2022 |
Application | Utility: COMBINATION THERAPIES USING CD-38 ANTIBODIES Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Grant | Utility: Nucleic acids encoding plasma kallikrein binding proteins Filling date: 7 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Anti-MIF immunohistochemistry Filling date: 7 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Fused heterocyclic compound Filling date: 7 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Bispecific antibodies against plasma kallikrein and Factor XII Filling date: 7 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: METHODS AND APPARATUSES FOR MODELING, SIMULATING, AND TREATING HEREDITARY ANGIOEDEMA Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A Filling date: 7 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: COMPOSITIONS OF THIENOPYRIMIDINE DERIVATIVES Filling date: 7 Sep 2025 Issue date: 30 Jun 2022 |
Grant | Design: Pusher foot for a fluid delivery device Filling date: 7 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Heteroaryl plasma kallikrein inhibitors Filling date: 7 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Assays for determining plasma kallikrein system biomarkers Filling date: 7 Sep 2025 Issue date: 28 Jun 2022 |
Application | Utility: MATRIX COMPOSITION Filling date: 7 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: ADENO ASSOCIATED VIRAL VECTOR DELIVERY OF ANTIBODIES FOR THE TREATMENT OF DISEASE MEDIATED BY DYSREGULATED PLASMA KALLIKREIN Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase Filling date: 7 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Inhibitors of plasma kallikrein and uses thereof Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: TREATMENT OF CNS CONDITIONS Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: ANTIBODY DRUG CONJUGATES Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Grant | Design: Display screen with a transitional graphical user interface Filling date: 7 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Prevention and reduction of blood loss Filling date: 7 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Metabolite biomarkers for diseases associated with the contact activation system Filling date: 7 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE Filling date: 7 Sep 2025 Issue date: 19 May 2022 |
Showing 1 to 50 of 339 patents.